America's Health Rankings, United Health Foundation Logo

Please tell us a little more about you

We appreciate you taking the time to help America’s Health Rankings better understand our audiences. Your feedback will allow us to optimize our website and provide you with additional resources in the future. Thank you.

Please select one option which best describes your profession or field of expertise

Journalist or media professional
Health Policy Professional
Public health professional (state, local, or community level)
Health care provider or administrator
Member of an advocacy group or trade organization
Academic, student, or researcher
Government administrator, legislator, or staffer
Concerned citizen
Other
Don't show me this again

RSV Vaccination - Age 60+ in South Dakota
search
South Dakota
search

Explore national- and state-level data for hundreds of health, environmental and socioeconomic measures, including background information about each measure. Use features on this page to find measures; view subpopulations, trends and rankings; and download and share content.

South Dakota Value:

35.9%

Percentage of adults age 60 and older who reported ever receiving an RSV vaccine

South Dakota Rank:

18

Value and rank based on data from 8/18/2024-1/4/2025

RSV Vaccination - Age 60+ in depth:

Appears In:

RSV Vaccination - Age 60+ by State

Percentage of adults age 60 and older who reported ever receiving an RSV vaccine

Search by State
Search for a state or tap below

RSV Vaccination - Age 60+ in

Data from U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey–Adult COVID Module, 8/18/2024-1/4/2025

>= 39.1%

35.9% - 39.0%

33.4% - 35.8%

29.5% - 33.3%

<= 29.4%

No Data

• Data Unavailable
Top StatesRankValue
250.5%
344.0%
Your StateRankValue
1736.1%
1935.3%
Bottom StatesRankValue
4626.3%
4725.3%

RSV Vaccination - Age 60+

250.5%
344.0%
440.9%
540.8%
640.6%
839.6%
939.1%
1038.4%
1137.9%
1237.7%
1337.5%
1437.1%
1536.6%
1636.4%
1736.1%
1935.3%
2034.8%
2334.5%
2434.4%
2634.0%
2733.5%
2833.4%
3032.4%
3032.4%
3331.8%
3530.3%
3629.9%
3729.8%
3829.5%
3929.4%
4129.0%
4328.3%
4427.5%
4526.8%
4626.3%
4725.3%
Utah
chevron-right
[2]
Data Unavailable
[2] Results are suppressed due to inadequate sample size and/or to protect identity
Source:
  • U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey–Adult COVID Module, 8/18/2024-1/4/2025

RSV Vaccination - Age 60+ Trends

Percentage of adults age 60 and older who reported ever receiving an RSV vaccine

About RSV Vaccination - Age 60+

US Value: 33.0%

Top State(s): New Mexico: 63.4%

Bottom State(s): Mississippi: 22.6%

Definition: Percentage of adults age 60 and older who reported ever receiving an RSV vaccine

Data Source and Years(s): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey–Adult COVID Module, 8/18/2024-1/4/2025

Suggested Citation: America's Health Rankings analysis of U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Immunization Survey–Adult COVID Module, United Health Foundation, AmericasHealthRankings.org, accessed 2025.

Respiratory syncytial virus (RSV) is a common respiratory virus that causes cold-like symptoms. RSV can lead to pneumonia and worsen underlying conditions such as asthma, chronic obstructive pulmonary disease (COPD) and heart failure. 

While RSV tends to be mild for healthy adults and children older than 6 months, older adults are more likely to develop severe illness and require hospitalization. Every year in the United States, an estimated 100,000-150,000 adults age 60 and older are hospitalized for RSV. 

The annual economic burden of RSV among adults age 60 and older in the United States is estimated at $6.6 billion in 2022 dollars.

The Centers for Disease Control and Prevention recommends the RSV vaccine for all adults age 75 and older, as well as for adults ages 60-74 with elevated risk factors for severe RSV. Conditions that increase the risk of severe RSV include:

  • Cardiovascular diseases, such as heart failure, coronary artery disease and congenital heart disease. 
  • Chronic lung and respiratory diseases, such as COPD, emphysema and asthma. 
  • End-stage renal disease.
  • Chronic liver disease.

Carrico, Justin, Katherine A. Hicks, Eleanor Wilson, Catherine A. Panozzo, and Parinaz Ghaswalla. “The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States.” The Journal of Infectious Diseases 230, no. 2 (August 16, 2024): e342–52. https://doi.org/10.1093/infdis/jiad559.

Current Reports

America’s Health Rankings builds on the work of the United Health Foundation to draw attention to public health and better understand the health of various populations. Our platform provides relevant information that policymakers, public health officials, advocates and leaders can use to effect change in their communities.

We have developed detailed analyses on the health of key populations in the country, including women and children, seniors and those who have served in the U.S. Armed Forces, in addition to a deep dive into health disparities across the country.